This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Aramark (ARMK) Q1 Earnings Miss Estimates
by Zacks Equity Research
Aramark (ARMK) delivered earnings and revenue surprises of -2.38% and 1.78%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Vital Farms (VITL): Can Its 6.8% Jump Turn into More Strength?
by Zacks Equity Research
Vital Farms (VITL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Beat the Market Like Zacks: JPMorgan Chase, Oracle, BioVie in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Vital Farms (VITL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 100% and 3.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include Vital Farms, Coupang and Webster Financial
by Zacks Equity Research
Vital Farms, Coupang and Webster Financial are part of the Zacks Screen of the Week article.
Buy 3 of the Best Stocks for Earnings Acceleration
by Tirthankar Chakraborty
Invest in stocks like Vital Farms (VITL), Coupang (CPNG) and Webster Financial (WBS) at the moment for superb earnings acceleration.
Chefs' Warehouse (CHEF) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chefs' Warehouse (CHEF) delivered earnings and revenue surprises of 51.85% and 8.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Vital Farms (VITL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Vital Farms (VITL) stock based on the movements in the options market lately.
Vital Farms (VITL) Reports Break-Even Earnings for Q2
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 100% and 4.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Darling Ingredients (DAR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Darling (DAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vital Farms (VITL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Vital Farms (VITL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vital Farms (VITL) Moves 16.1% Higher: Will This Strength Last?
by Zacks Equity Research
Vital Farms (VITL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Vital Farms (VITL) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 33.33% and 1.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Vital Farms (VITL) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 0% and 6.05%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
MGP (MGPI) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
MGP (MGPI) delivered earnings and revenue surprises of 27.94% and 7.37%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Medifast (MED) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 8.99% and 0.49%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Vital Farms (VITL) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 50.00% and 1.85%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Vital Farms (VITL) Q3 Earnings Expected to Decline
by Zacks Equity Research
Vital Farms (VITL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vital Farms (VITL) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 1000.00% and 4.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Vital Farms (VITL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Vital Farms (VITL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vital Farms (VITL) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Vital Farms (VITL) has been struggling lately, but the selling pressure may be coming to an end soon
Food Stocks' Earnings Roster for May 11: DAR, ARMK, BGS, VITL
by Zacks Equity Research
Food stocks are expected to reflect gains from strong demand stemming from higher at-home consumption trends amid the pandemic.